stars 1 stars 2 stars 3

Cell-Easy is a CDMO specialized in Cell Therapy. We support biotech, pharma, and public institutions with GMP development and manufacturing. Our mission: accelerate your Cell Therapy’s path to market, with patient access as our priority. ATMPs are not conventional biologics — they are living drugs. Our team brings hands-on expertise in cell culture across all cell types, engineered or not, addressing challenges in development, GMP manufacturing, and QC. Beyond core CDMO services — process diagnostics, development, GMP production, cell banking, cryostorage, and delivery — we also support sourcing of human biological materials and clinical trial setup, helping you move efficiently from concept to clinic. We’ve supported 10 clinical trials to date, including projects with top 30 pharma, and helped clients shift from autologous to allogeneic approaches. More at: www.cell-easy.com

Cell-Easy Questions

The Cell-Easy annual revenue was $5.8 million in 2026.

Benedikt Timmerman is the Co-Founder ; Non Executive Board Member of Cell-Easy.

28 people are employed at Cell-Easy.

Top Cell-Easy Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users